EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

The rise and future of peptide-based antimicrobials

Hyo Jung Kim

Journal of Microbiology · 2026

DOI: 10.71150/jm.2510002 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Microbiology, 2026. Verfasst von Hyo Jung Kim. Beteiligte Einrichtung: College of Pharmacy, Woosuk University, Wanju 55338, Republic of Korea. Hauptthemen laut MEDLINE: Antimicrobial Peptides, Anti-Bacterial Agents, Peptides, Anti-Infective Agents. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 92 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Education, Jeonbuk State, Woosuk University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The escalating threat of antimicrobial resistance has renewed global interest in peptide-based antibiotics as adaptable and effective alternatives to conventional small molecules. Peptides possess diverse mechanisms of action, high target specificity, and structural flexibility, which collectively limit the emergence of resistance. This review outlines recent advances spanning the discovery, optimization, and application of peptide antibiotics, from their biological origins and structural classifications to emerging strategies involving artificial intelligence, synthetic biology, and modern delivery technologies. Peptide antibiotics can be categorized by origin as natural, semi-synthetic, or fully synthetic, and further organized by structural class such as α-helical, β-sheet, cyclic, and extended forms. They are also grouped by function into membrane-targeted and non-membrane-targeted types. These classification schemes are not only descriptive but also critical for understanding the therapeutic potential of peptides, as each category presents distinct advantages and engineering challenges that influence stability, specificity, and overall clinical performance. Advances in artificial intelligence, synthetic biology, and continuous manufacturing are reshaping how peptide drugs are designed and produced, while innovations in drug delivery systems are addressing critical issues of stability and bioavailability. Together, these developments are laying the foundation for a new generation of peptide-based therapeutics capable of meeting the evolving challenges of antimicrobial resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antimicrobial PeptidesAnti-Bacterial AgentsPeptidesAnti-Infective AgentsHumansArtificial IntelligenceSynthetic BiologyDrug Delivery SystemsBacteriaDrug Resistance, Bacterial

Stichwörter der Autor:innen

antimicrobial resistanceartificial intelligencedrug delivery systemspeptide antibioticssynthetic biology

Substanzen

Antimicrobial PeptidesAnti-Bacterial AgentsPeptidesAnti-Infective Agents

Autor:innen und Institutionen

  • College of Pharmacy, Woosuk University, Wanju 55338, Republic of Korea.

Förderung

  • Ministry of Education
  • Jeonbuk State
  • Woosuk University

Zitieren

APA

Kim, H. J. (2026). The rise and future of peptide-based antimicrobials. Journal of Microbiology. https://doi.org/10.71150/jm.2510002

Vancouver

Kim HJ. The rise and future of peptide-based antimicrobials. Journal of Microbiology. 2026. doi:10.71150/jm.2510002

BibTeX
@article{Kim2026,
  author = {Kim, Hyo Jung},
  title = {The rise and future of peptide-based antimicrobials},
  journal = {Journal of Microbiology},
  year = {2026},
  doi = {10.71150/jm.2510002}
}
Kostenlos starten →